Advanced Cardiac Therapeutics Completes $5 Million Financing
Laguna Beach, California (ots/PRNewswire) - Advanced Cardiac Therapeutics, Inc. ("ACT"), a developer of advanced irrigated cardiac ablation systems, announced today that it has completed a $5 million 'Series B' equity financing. The financing was led by NBGI Ventures, a venture capital firm specialized in medical technology investments, and is expected to fund commercialisation in Europe. ACT was founded in 2007 to ...
plus